Breaking

Morning brief: US-China talks,Trump vs Fed, UK-US nuclear deal, xAI Layoffs
Australia’s looming climate crisis: report warns of intensifying extreme events
Singapore’s new home sales hit 9-month high in August
Europe stocks open in the green: FTSE up 0.2%, DAX climbs 0.4%
Sainsbury’s shares hit four-year high as Argos sale talks with JD.com collapse
US and Europe’s continued trade with Russia raises sanction efficacy questions
Why India’s gold demand is expected to dip this festive season
Germany to phase out fixed-price contracts for renewables

Business
Investing
Stocks
World
Search for:

Investing

Acceleration of RAD204 Phase 1 dose escalation trial

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Completion of Non-Renounceable Pro-Rata Entitlement Offer

September 15, 2025

Significant Enlargement of Exploration Program

September 15, 2025

Locksley Resources LimitedSignificant Enlargement of Exploration Program

September 15, 2025

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (200)
- Investing (890)
- Stocks (1,106)
- World (1,056)

Disclaimer: perfectdaytrading.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 perfectdaytrading.com | All Rights Reserved

Top

Business
Investing
Stocks
World

Type above and press Enter to search. Press Esc to cancel.